The stock has a 36-month beta value of 0.93. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for VRPX is 18.04M, and at present, short sellers hold a 3.50% of that float. On February 14, 2025, the average trading volume of VRPX was 3.89M shares.
VRPX) stock’s latest price update
Virpax Pharmaceuticals Inc (NASDAQ: VRPX)’s stock price has plunge by 7.64relation to previous closing price of 0.27. Nevertheless, the company has seen a 6.25% surge in its stock price over the last five trading sessions. businesswire.com reported 2025-01-31 that BERWYN, Pa.–(BUSINESS WIRE)–Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, is pleased to announce its senior director of portfolio management, Matthew Barnes, will be presenting at Outsourcing in Clinical Trial Conference. The Outsourcing in Clinical Trials (OCT) is a leading confer.
VRPX’s Market Performance
Virpax Pharmaceuticals Inc (VRPX) has seen a 6.25% rise in stock performance for the week, with a -17.22% decline in the past month and a -56.33% plunge in the past quarter. The volatility ratio for the week is 9.98%, and the volatility levels for the past 30 days are at 10.59% for VRPX. The simple moving average for the past 20 days is -1.10% for VRPX’s stock, with a -63.29% simple moving average for the past 200 days.
VRPX Trading at -13.86% from the 50-Day Moving Average
After a stumble in the market that brought VRPX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.73% of loss for the given period.
Volatility was left at 10.59%, however, over the last 30 days, the volatility rate increased by 9.98%, as shares sank -16.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -37.35% lower at present.
During the last 5 trading sessions, VRPX rose by +6.25%, which changed the moving average for the period of 200-days by -90.68% in comparison to the 20-day moving average, which settled at $0.2921. In addition, Virpax Pharmaceuticals Inc saw -23.95% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for VRPX
The total capital return value is set at 6.52. Equity return is now at value -594.46, with -198.45 for asset returns.
Currently, EBITDA for the company is -15.19 million with net debt to EBITDA at 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.08.
Conclusion
To sum up, Virpax Pharmaceuticals Inc (VRPX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
